In a world increasingly driven by digital innovation, it’s no surprise that the healthcare industry is evolving to incorporate technology into treatment plans and mechanisms. This evolution has given rise to a fascinating sector known as digital therapeutics. However, to fully grasp the magnitude of its revolutionary impact, it’s crucial that we delve into the statistics that underline its growth trajectory. In this blog post, we will comprehensively explore the digital therapeutics market size, shedding light on its current landscape and potential future growth. We will delve into factors driving this growth and what these numbers signify for healthcare providers, technology developers, and patients. Welcome to a new era of medical treatment where technology is not just an accessory, but an essential component of healthcare delivery.

The Latest Digital Therapeutics Market Size Statistics Unveiled

The global digital therapeutics market size was valued at USD 2.69 billion in 2019.

Framing the grandeur of the digital therapeutics landscape, this statistic spectacularly showcases an encapsulation of its financial power. The discernible figure of USD 2.69 billion in 2019 illustrates the sheer magnitude, confirming its standing as an influential player within the global economy. As we journey through this blog post, let this number serve as a factual footprint, the first of many stepping stones to understanding the intricate web of the digital therapeutics market. Its surprising enormity and impact are invaluable to the comprehension of subsequent trends, shifts, and forecasts that will unfurl in the course of this blog post. By having this empirical benchmark, we can venture into the depth and complexities of the market, creating a rich tapestry of statistics that are comprehensible to both industry professionals and casual readers.

The Digital Therapeutics Market was expected to grow at a CAGR of 20.5% over the forecast period 2021 to 2026.

Drawing our attention to the compelling forecast of a 20.5% CAGR for the Digital Therapeutics Market from 2021 to 2026, we see a vibrant and expanding industrial narrative just beginning to unfold. This prolific growth-rate prospect not only reflects the dynamic nature of the sector but is also a testament to the accelerated adoption and growing demand for digital therapeutics. This numeric predictor paints a picture of a future where digital therapeutics become an integral part of healthcare worldwide. As a lens to the past and a telescope to the future, this statistic speaks to the potential for investors, stakeholders, and innovators in the market, lighting the path forward with projections of robust, sustained growth.

North America accounted for the largest market share of 35.5% in 2020.

Highlighting North America’s substantial command of the digital therapeutics market in 2020, with an impressive stake of 35.5%, signifies the region’s robust influence and potential growth in this specific area. This commanding figure not only positions North America as a key player, but also illustrates its importance as a strategic market for stakeholders seeking opportunities or planning expansions in the digital therapeutics sector. Observing such market prevalence offers valuable insights to help forecast trends, make informed decisions, and gauge the overall pulse of the digital therapeutics market.

The Asia-Pacific region expected to register a significant growth rate of over 24% in the digital therapeutics market.

This compelling statistic breathes life into the narrative around the growth potential of the digital therapeutics market in the Asia-Pacific region. The astonishing projected rate of over 24% situates this region as a dynamic player in the global market. It underscores a vibrant opportunity for investors, digital health services, and pharmaceutical companies to innovate, expand, and reap substantial returns. Therefore, any comprehensive analysis or discourse about market size in digital therapeutics would be incomplete without mentioning this significant growth trajectory.

Diabetes application held a major market share of nearly 23% in the digital therapeutics market.

Illustrating the dominance of Diabetes applications in the digital therapeutics market, the statistic underscores that almost a quarter of this burgeoning industry is committed towards managing and treating this chronic condition. The magnitude of this share indicates the sizeable demand and utility that these digital tools have for diabetic patients, shaping the trajectory of the sector. Furthermore, it emphasizes uncovered opportunities for developers to innovate and produce apps for other medical conditions that could rival, if not surpass, the prominence of diabetes within the digital therapeutics landscape.

The market size for digital therapeutics in the U.S.A was valued at USD 889.27 Million in the year 2019.

Delving into the vibrant domain of digital therapeutics, the U.S.A market’s valuation at a robust USD 889.27 Million in 2019 paints an intriguing picture. This figure tells a story; a narrative of an emergent industry on the cusp of skyrocketing. It’s not just a number but a strong testament to the rapidly embracing consensus on digital therapeutics across the healthcare continuum. This potent clue of the past underscores the potential, significance, and growth trajectory of this nascent sector. So, as we journey into the depths of the digital therapeutics market size, this statistic serves as our robust anchor, offering us valuable perspectives and insights.

The mental & behavioral health sector in digital therapeutics is predicted to earn revenue of close to USD 2 billion by 2026.

Drilling down into the heart of the digital therapeutics market, it’s truly striking to spotlight the expected mental and behavioral health sector’s contribution. By diving into a treasure chest as valuable as nearly USD 2 billion by 2026, it generates intense excitement within industry circles. This projection decodes the enormous potential and the escalating commitment to harness digital solutions for mental and behavioral health issues. Indeed, it unveils the urgency to augment traditional medical methods with digital resources, speaking volumes about the future direction of healthcare. More significantly, it punctuates how digital advancements are poised to revolutionize not just the entirety of healthcare, but particularly, the often overlooked areas of mental and behavioral well-being.

Providers end-user segment is expected to grow at a CAGR of nearly 20% from 2021 to 2028 in the digital therapeutics market.

The projected growth of a nearly 20% Compound Annual Growth Rate (CAGR) for the providers end-user segment in the digital therapeutics market from 2021 to 2028 offers a glimpse into the escalating demand in this field. Unfolding an intriguing narrative of expansion, this statistic not only signifies the snowballing interest among providers but also underscores the potential market shift that could profoundly reshape the landscape of digital therapeutics. In the age of rapidly advancing technology, such substantial growth could be indicative of a sweeping adoption of digital therapeutics by providers. Critical to the understanding of the market size’s future trajectory, this figure permits stakeholders across the spectrum to gauge possible opportunities, thus aiding in making informed strategic decisions.

To date, over 127 companies are operating in the digital therapeutics space globally.

Highlighting that over 127 companies are actively partaking in the global digital therapeutics space offers a valuable panorama of the market landscape. This not only demonstrates the level of existing competition but also signifies the attractiveness and potential growth this burgeoning industry entails. As a digital testament to the technological evolution, these numbers symbiotically bridge the gap between average layman and industry followers about digital therapeutics market size, underlining its continuous expansion and the proliferating acceptance and trust of stakeholders in the digital healthcare sphere.

The digital therapeutics market is projected to reach an estimated value of $13.1 billion globally by 2023.

In unveiling the potential magnitude of the digital therapeutics market, this statistic draws attention to a staggering projected value of $13.1 billion globally by 2023. It instantaneously propels the readers into a horizon imbued with numerous opportunities and rapid growth awaiting to be capitalized on. This projection is a clarion call to investors, digital health companies, and health care providers, identifying digital therapeutics as a sector that’s simply too substantial to ignore. It also underlines the accelerating trend towards digitalization in healthcare, implying significant advancements and increased adoption of digital therapeutics in our near future.

The payer adoption segment held the largest share of the digital therapeutics market in 2020.

Delving into the riveting world of digital therapeutics market, it is pertinent to highlight that the payer adoption segment commanded the lion’s share in 2020. Considering this significant piece of data allows us to unravel the intriguing dynamics of the market. The predominance of the payer adoption segment might be indicative of the shifting patterns in healthcare, pointing to the rising influence of payers in determining the rate and extent of digital therapeutics adoption. This piece of information can artistically paint a comprehensive picture of the market to stakeholders, revealing where power lies, and may serve as the compass guiding investment decisions, formulation of market strategies and policy development in the rapidly evolving digital therapeutics industry.

54% of the digital therapeutics companies were based in North America in 2020.

Highlighting the statistic that North America was home to 54% of digital therapeutics companies in 2020 throws a striking spotlight on the region’s commanding lead in this rapidly expanding field. It underscores North America’s robust health tech ecosystem, ripe with innovation, tech-savvy talent, and ample funding opportunities. In the context of our exploration of the digital therapeutics market size, this figure is a testament to the region’s significant role in driving the market and setting trends. Equally important, it sparks curiosity about what other regions are doing and how they compare, further enriching our greater market size discussion.

The digital therapeutics market in Europe was expected to generate a revenue of over USD 1.2 billion in 2025.

Highlighting the anticipated revenue generation of over USD 1.2 billion by 2025 in Europe’s digital therapeutics market can dramatically illustrate the tremendous growth trajectory and immense potential of this sector. It paints a vivid picture of a future where digital therapeutics will play an indispensable role, thus stimulating interest and conversations around the significant economic implications tied to this rise. This statistic also underscores the potential opportunities for investors, start-ups, and healthcare organizations to carve out their niche in this billion-dollar landscape. Essentially, it delivers an influential narrative about the market size, while also hinting at the broader socio-economic and health-related impacts of digital therapeutics advancements.

“Software as a Prescription” Digital Therapeutics held the maximum market share of 56% in 2020.

Highlighting the statistic that “Software as a Prescription” Digital Therapeutics commanded a prominent market share of 56% in 2020, provides valuable insight for those looking to comprehend the paradigm shifts in the digital therapeutics market. The predominance of this specific sub-sector underscores its acceptance and dependability among consumers, a vital factor for potential investors, developers, and health care providers to acknowledge. Such compelling numbers serve as a key indicator of market trends, current consumer preferences, and potential areas of growth within the sector. Understanding these elements is pivotal for strategic decision-making, providing rich context in a blog post that aims to decode the magnitudes and trends in the digital therapeutics market.

Obesity therapeutic application is expected to grow at the highest CAGR of about 34.0% from 2021 to 2028.

Navigating the thrilling waves of the digital therapeutics market, one cannot ignore the colossal swell anticipated for obesity therapeutic applications. Projected to rocket with a staggering CAGR of around 34.0% from 2021 to 2028, this data nugget becomes a pivotal point of focus. Within the article’s tapestry of statistics and market size data, this specific statistic presents itself as a powerful indicator of future trends, revealing a glaring opportunity for growth and investment in a digital solution for a global health crisis. The message is clear: those sailing aboard the ship of digital therapeutics should set their course toward the impressive and fast-growing obesity sector, where the wind of demand is blowing strongly.


In essence, the digital therapeutics market is on a strong upward trajectory and is anticipated to burgeon remarkably in the coming years. Factors such as technological advancements, increasing incidences of chronic diseases, growing focus on preventive healthcare, and global health crises are contributing to this unparalleled growth. However, the broader adoption still faces the hurdles of regulatory inconsistencies and data privacy concerns. Despite these challenges, with the continual digitization of healthcare and an increasingly health-conscious global population, the market for digital therapeutics is undeniably promising. Thus, whether you are a healthcare provider, an investor, or a digital health enthusiast, keeping an eye on the bustling activity in the digital therapeutics space will be rewarding.


0. –

1. –

2. –

3. –

4. –

5. –

6. –

7. –

8. –

9. –

10. –

11. –

12. –

13. –

14. –